Written by Amani Nilar
22 Dec, 2021 | 5:28 pm
(News 1st); The researchers at Melbourne University and the Monash University in Melbourne in collaboration, Australia have manufactured a blood thinner to be sprayed into the nose as a trial drug against COVID-19.
The newly manufactured drug, ‘Nasal Spray’ to obtain protection against COVID-19.
However, this drug will not be introduced for commercial use until mid-2022.
Moreover, if the drug is used alongside vaccines, it could benefit as an additional immunity booster, stated Australian researchers.
Furthermore, they stated the spray could help both as early treatment and as a nasal mask to stop the virus from spreading from person to person.
Moreover, the researchers stated that it has been recommended to draw two puffs, three times a day to see if the drug works to prevent household transmission and infecting non-infected residents. If it proves to be effective, it can be globally distributed as an effective drug against COVID-19.
26 Jul, 2022 | 06:16 PM
18 Jul, 2022 | 11:25 AM
Are you interested in advertising on our website or video channel
Please contact us at [email protected]